T45.6
T45.6: Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs
Non-billable headerICD-10-CM
T45.6 is a non-billable header ICD-10-CM code for poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs. It cannot be billed on its own: choose one of the more specific child codes below. This code also requires a 7th character before it is complete.
This code requires a 7th character
The appropriate 7th character is to be added to each code from category T45
- A
- initial encounter
- D
- subsequent encounter
- S
- sequela
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Code history
Unchanged in every release from FY2024 to FY2027.
Code to one of these instead T45.6
4 child codes. Green means billable.
- T45.60Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs
- T45.61Poisoning by, adverse effect of and underdosing of thrombolytic drugs
- T45.62Poisoning by, adverse effect of and underdosing of hemostatic drugs
- T45.69Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs
Other codes under T45
- T45.0Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs
- T45.1Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
- T45.2Poisoning by, adverse effect of and underdosing of vitamins
- T45.3Poisoning by, adverse effect of and underdosing of enzymes
- T45.4Poisoning by, adverse effect of and underdosing of iron and its compounds
- T45.5Poisoning by, adverse effect of and underdosing of anticoagulants and antithrombotic drugs
- T45.7Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants
- T45.8Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents
- T45.9Poisoning by, adverse effect of and underdosing of unspecified primarily systemic and hematological agent
- T45.APoisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs